/EXM.CN
EXM.CN Stock - EXMceuticals Inc.
Healthcare|Drug Manufacturers - Specialty & GenericCNQ
$0.20+0.00%
+$0.00 (+0.00%) • Feb 26
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.86
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.22
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for EXM.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.20 – $0.20
TARGET (TP)$0.23
STOP LOSS$0.18
RISK/REWARD1:1.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.85
52W High$0.20
52W Low$0.20
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-39.594 | $-617.166 | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-7,857,666 | $-9,747,154 | $-1,323.743 | $-370.26 | $-304,950 |
| Net Income | $-9,806,187 | $-9,758,138 | $-1,324.258 | $-370.26 | $-495,609 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.25 | $-0.25 | $-0.00 | $-0.00 | $-0.04 |
Company Overview
EXMceuticals Inc. engages in the production of cannabinoid formulations. The company primarily focuses around the matching of natural bioactive ingredients extracted from the cannabis plant with the needs of the nutraceutical, cosmeceutical, therapeutic, and pharmaceutical industries. It focuses on the production of CBD, a non-psychoactive cannabinoid that has been proven effective against acne, anxiety, depression, epilepsy, and degenerative diseases, such as Parkinson's; and THC, a psychoactive cannabinoid ingredient that has been proven effective in the fields of pain management, appetite control, anxiety, and managing side effects of chemotherapy. The company was incorporated in 2008 and is headquartered in Quebec, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
EXM.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.03
Q1 2021
EPS Surprise History
Q2 19
No data
Q4 19
No data
Q4 19
No data
Q1 20
No data
Q2 20
No data
Q3 20
No data
Q4 20
No data
Q1 21
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2021 | Mar 31, 2021 | — | $-0.03 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.02 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.04 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.09 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.08 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.04 | — | — |
Q4 2019 | Dec 27, 2019 | — | $-0.04 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.07 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.15 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.00 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-0.02 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.00 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-0.01 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.01 | — | — |
Q3 2017 | Sep 30, 2017 | — | $-0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.01 | — | — |
Q1 2017 | Mar 31, 2017 | — | $-0.00 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.00 | — | — |
Q3 2016 | Sep 30, 2016 | — | $-0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about EXM.CN
What is EXM.CN's current stock price?
EXMceuticals Inc. (EXM.CN) is currently trading at $0.20 per share. The stock has moved +0.00% today.
What is the analyst price target for EXM.CN?
No analyst price targets are currently available for this stock.
What sector is EXMceuticals Inc. in?
EXMceuticals Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the CNQ exchange.
What is EXM.CN's market cap?
EXMceuticals Inc. has a market capitalization of $0.02 billion, making it a small-cap company.
Does EXM.CN pay dividends?
No, EXMceuticals Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATE.TO
Antibe Therapeutics Inc.
$0.29
Mkt Cap: $0.0B
AYR-A.CN
Ayr Wellness Inc.
$0.15
Mkt Cap: $0.0B
CHAL.CN
Chalice Brands Ltd.
$0.23
Mkt Cap: $0.0B
CNFA.CN
CanaFarma Hemp Products Corp.
$0.05
Mkt Cap: $0.0B
IMCC.CN
IM Cannabis Corp.
$5.10
Mkt Cap: $0.0B
LXG.V
LexaGene Holdings Inc.
$0.10
Mkt Cap: $0.0B
MRV.TO
Nuvo Pharmaceuticals Inc.
$1.35
Mkt Cap: $0.0B
NUMI.TO
Numinus Wellness Inc.
$0.05
Mkt Cap: $0.0B
ORI.CN
Orion Nutraceuticals Inc.
$0.40
Mkt Cap: $0.0B
RIV.CN
RIV Capital Inc.
$0.10
Mkt Cap: $0.0B
Explore stocks similar to EXM.CN for comparison